Skip to main content

Table 1 The central composite design and the observed values are used to optimize the RP-UPLC method for Ensifentrine optimization

From: Integrating green analytical chemistry and analytical quality by design: an innovative approach for RP-UPLC method development of ensifentrine in bulk and inhalation formulations

Run No

Run

A: Flow rate (Factor 1, mL/min)

B: Organic Phase-Mobile phase (Factor 2, %)

C: Temperature (Factor 3, oC)

Response 1

(RT-Retention Time, min)

Response 2 (NTP-Number of Theoretical Plate, min)

Response 3(TF-Tailing Factor, min)

1

11

0.27

25

27

1.266

4176.2

1.1

2

8

0.33

25

27

1.056

2531.1

1.03

3

2

0.27

35

27

1.291

4140.1

1.1

4

16

0.33

35

27

1.078

2588.5

1.1

5

19

0.27

25

33

1.189

2874.1

1.1

6

6

0.33

25

33

1.001

2455

1

7

17

0.27

35

33

1.215

2980.9

1.11

8

9

0.33

35

33

1.028

2470.2

1.1

9

12

0.249546

30

30

1.328

4254.8

1.1

10

7

0.350454

30

30

0.979

2380

1.04

11

10

0.3

21.591

30

1.118

2791.8

1.02

12

4

0.3

38.409

30

1.163

2797.7

1.1

13

1

0.3

30

24.9546

1.197

3349.7

1.1

14

15

0.3

30

35.0454

1.063

2591.5

1.1

15

18

0.3

30

30

1.121

2697

1.08

16

14

0.3

30

30

1.123

2693

1.08

17

5

0.3

30

30

1.124

2709

1.07

18

3

0.3

30

30

1.124

2724

1.08

19

20

0.3

30

30

1.134

2804

1.08

20

13

0.3

30

30

1.135

2791

1.08